Saifulazmi N, Rohani E, Harun S, Bunawan H, Hamezah H, Nor Muhammad N
Life (Basel). 2022; 12(8).
PMID: 36013466
PMC: 9410304.
DOI: 10.3390/life12081287.
Boika A, Sialitski M, Chyzhyk V, Ponomarev V, Fomina E
Clin Case Rep. 2021; 9(7):e04409.
PMID: 34257979
PMC: 8259921.
DOI: 10.1002/ccr3.4409.
Zhou Y, Pu J, Wu Y
Pathogens. 2021; 10(3).
PMID: 33807642
PMC: 7998359.
DOI: 10.3390/pathogens10030303.
Sethi A, Bach H
Microorganisms. 2020; 8(8).
PMID: 32707942
PMC: 7463960.
DOI: 10.3390/microorganisms8081097.
Zhang P, Moreno R, Lambert P, DiMaio D
Proc Natl Acad Sci U S A. 2020; 117(11):6121-6128.
PMID: 32123072
PMC: 7084110.
DOI: 10.1073/pnas.1917748117.
Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning.
Kaiser M, Maser P, Tadoori L, Ioset J, Brun R
PLoS One. 2015; 10(8):e0135556.
PMID: 26270335
PMC: 4535766.
DOI: 10.1371/journal.pone.0135556.
Computational Docking Study of p7 Ion Channel from HCV Genotype 3 and Genotype 4 and Its Interaction with Natural Compounds.
Mathew S, Fatima K, Fatmi M, Archunan G, Ilyas M, Begum N
PLoS One. 2015; 10(6):e0126510.
PMID: 26030803
PMC: 4451521.
DOI: 10.1371/journal.pone.0126510.
Camphor-based symmetric diimines as inhibitors of influenza virus reproduction.
Sokolova A, Yarovaya O, Korchagina D, Zarubaev V, Tretiak T, Anfimov P
Bioorg Med Chem. 2014; 22(7):2141-8.
PMID: 24631360
PMC: 7126937.
DOI: 10.1016/j.bmc.2014.02.038.
The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.
Wanka L, Iqbal K, R Schreiner P
Chem Rev. 2013; 113(5):3516-604.
PMID: 23432396
PMC: 3650105.
DOI: 10.1021/cr100264t.
Mechanism of function of viral channel proteins and implications for drug development.
Fischer W, Wang Y, Schindler C, Chen C
Int Rev Cell Mol Biol. 2012; 294:259-321.
PMID: 22364876
PMC: 7149447.
DOI: 10.1016/B978-0-12-394305-7.00006-9.
Hepatitis C virus p7-a viroporin crucial for virus assembly and an emerging target for antiviral therapy.
Steinmann E, Pietschmann T
Viruses. 2011; 2(9):2078-2095.
PMID: 21994720
PMC: 3185753.
DOI: 10.3390/v2092078.
The host interactome of influenza virus presents new potential targets for antiviral drugs.
Shaw M
Rev Med Virol. 2011; 21(6):358-69.
PMID: 21823192
PMC: 3207218.
DOI: 10.1002/rmv.703.
Ion channels as antivirus targets.
Liang X, Li Z
Virol Sin. 2010; 25(4):267-80.
PMID: 20960300
PMC: 8227895.
DOI: 10.1007/s12250-010-3136-y.
Where does amantadine bind to the influenza virus M2 proton channel?.
Kozakov D, Chuang G, Beglov D, Vajda S
Trends Biochem Sci. 2010; 35(9):471-5.
PMID: 20382026
PMC: 2919587.
DOI: 10.1016/j.tibs.2010.03.006.
Virus entry paradigms.
Kalia M, Jameel S
Amino Acids. 2009; 41(5):1147-57.
PMID: 19826903
PMC: 7088018.
DOI: 10.1007/s00726-009-0363-3.
Distribution and dynamics of adamantanes in a lipid bilayer.
Chew C, Guy A, Biggin P
Biophys J. 2008; 95(12):5627-36.
PMID: 18835906
PMC: 2599851.
DOI: 10.1529/biophysj.108.139477.
Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity.
Hoffmann H, Palese P, Shaw M
Antiviral Res. 2008; 80(2):124-34.
PMID: 18585796
PMC: 2614658.
DOI: 10.1016/j.antiviral.2008.05.008.
Design, synthesis, and trypanocidal activity of new aminoadamantane derivatives.
Papanastasiou I, Tsotinis A, Kolocouris N, Prathalingam S, Kelly J
J Med Chem. 2008; 51(5):1496-500.
PMID: 18281929
PMC: 2430315.
DOI: 10.1021/jm7014292.
Structure and mechanism of the M2 proton channel of influenza A virus.
Schnell J, Chou J
Nature. 2008; 451(7178):591-5.
PMID: 18235503
PMC: 3108054.
DOI: 10.1038/nature06531.
Solid-state NMR characterization of conformational plasticity within the transmembrane domain of the influenza A M2 proton channel.
Li C, Qin H, Gao F, Cross T
Biochim Biophys Acta. 2007; 1768(12):3162-70.
PMID: 17936720
PMC: 2258276.
DOI: 10.1016/j.bbamem.2007.08.025.
